Azịza ngwa ngwa
A stock-price return does not set a peptide quality standard or identify why investors valued a company. This article evaluates integrated workflow evidence wi…
Kedu uru otu afọ Thermo Fisher na-enweta n'ezie n'ihe gbasara akụrụngwa sayensị nke ndụ?
<klas ọgụgụ ="blọọgụ-akara ngosi" ụdị ="oke-obosara:640px;oke:1.5rem akpaaka;font-nha:12px;ahịrị-ịdị elu:1.3;agba:eketa"> <svg viewBox="0 0 560 380" ụdị ="oke-obosara: 100%; elu: akpaaka; font-ezinụlọ: 'Inter', usoro-ui, sans-serif; agba: #1e293b; --chaatị-mechiri emechi: #64748b;" ọrụ ="img" aria-labeledby="thermo-fisher-fy2025-ngalaba-ụtara ego-aha thermo-fisher-fy2025-ngalaba-ego-desc"> <ịke> /* Onye nrụpụta na-etinye eserese ahụ n'ime iframe nke ihe ndabere ya dị oji, na iframe bụ ọdịdị dị iche na chaatị ahụ, ya mere eriri igbe akwụkwọ ozi gosipụtara dị ka okpokolo agba gbara ya gburugburu (prod 09-22). Akwụkwọ dị n'ime iframe pụtara ìhè na ndabara; esere ya ebe a na-ekpuchi ndabere elementrị, na mgbe e debere chaatị ahụ kama nke a dabara na ihe ọ bụla. Debe brackets n'akuku na ngọngọ a: A na-atụgharị akụkụ ụdị n'ime SVG dị ka ọdịnaya nke mba ọzọ, ya mere otu nkwado kpafuru akpafu na-atụfu iwu niile dị na ya. */ html, ahu { ndabere: #fffff; oke: 0; } @mgbasa ozi (na-ahọrọ-ebelata-mmegharị: belata) { * { animation: onweghi !mkpa; mgbanwe: onweghi !mkpa; } } </ịke> <ziri ezi x="0" y="0" obosara ="560" elu ="380" rx="8" juru ="#fffff" /> <aha id="thermo-fisher-fy2025-akụkụ-ego-aha">Ego ntinye ego nke Thermo Fisher FY2025</aha> <desc id ="thermo-fisher-fy2025-ngalaba-ego-desc">Ngwaahịa ụlọ nyocha na ọrụ Biopharma butere ego n'akụkụ FY2025 na $ 23.984B, n'ihu Life Sciences Solutions na $10.374B, Ngwa nyocha na $8.259B na Ọpụrụiche Diagnostics na $4.939B. Ego ntinye ego nke Thermo Fisher FY2025. data mgbochi kwụ ọtọ: Ngwaahịa ụlọ nyocha & Biopharma 23.984; Ngwọta Sayensị Ndụ 10.374; Ngwa nyocha 8.259; Ọpụrụiche Diagnostics 4.939.Isi mmalite: Thermo Fisher Sayensị, FY2025 Ụdị 10-K 2025.</desc> <ederede x ="280.0" y="29" ederede-arịlịka ="etiti" font-size ="18" font-arọ="800" juru ="Agba ugbu a">Ego ntinye ego nke Thermo Fisher FY2025</ederede> <ahịrị x1="145" y1="298.0" x2="510" y2="298.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="243.0" x2="510" y2="243.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="188.0" x2="510" y2="188.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="133.0" x2="510" y2="133.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="78.0" x2="510" y2="78.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ederede x ="136.0" y="109.8" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">Ngwaahịa ụlọ nyocha &</tsp><otu x ="136.0" dy="12">Biopharma</tsp></ederede> <ziri ezi x="145" y="78.0" obosara ="365.0" elu ="49.0" rx="4" juru ="#f97316" /> <ederede x ="518.0" y="109.8" font-size ="11" juru ="Agba ugbu a">23.984</ederede> <ederede x ="136.0" y="166.8" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">Ndụ sayensị</tsp><otu x ="136.0" dy="12">Ngwọta</tsp></ederede> <ziri ezi x="145" y="135.0" obosara ="157.9" elu ="49.0" rx="4" juru ="#38bdf8" /> <ederede x ="310.9" y="166.8" font-size ="11" juru ="Agba ugbu a">10.374</ederede> <ederede x ="136.0" y="223.8" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">Nyocha</tsp><otu x ="136.0" dy="12">Ngwa ngwa</tsp></ederede> <ziri ezi x="145" y="192.0" obosara ="125.7" elu ="49.0" rx="4" juru ="#nke 78bfa" /> <ederede x ="278.7" y="223.8" font-size ="11" juru ="Agba ugbu a">8.259</ederede> <ederede x ="136.0" y="280.9" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">Ọpụrụiche</tsp><otu x ="136.0" dy="12">Nchọpụta nchọpụta</tsp></ederede> <ziri ezi x="145" y="249.0" obosara ="75.2" elu ="49.0" rx="4" juru ="#22c55e" /> <ederede x ="228.2" y="280.9" font-size ="11" juru ="Agba ugbu a">4.939</ederede> <ederede x ="280.0" y="366" ederede-arịlịka ="etiti" font-size ="10" juru ="anyi(--chaatị-mechiri emechi, Agba ugbu a)">Isi mmalite: Thermo Fisher Sayensị, FY2025 Ụdị 10-K (2025)</ederede> </svg> </ọgụgụ>
Ụlọ ọrụ nyocha Peptide Peptides megharia Uru ahụ na-esokwa ngwá ọrụ dị iche iche, consumable na ọrụ azụmahịa, ọ bụghị peptide nzọ. Ọnụ ego nke Thermo Fisher 2025 akụkọ kwa afọ na-etinye ego agbakwunyere na $44,556 nde, elu 4% kọrọ na 2% organic si $42,879 nde in 2024, ya na Ngwaahịa Laboratory na Ọrụ Biopharma na $23,984 nde na Life Sciences Solutions na $10,374 nde. Nkebi nke 10-K ya depụtara ngwa nyocha na $7,554 nde na Specialty Diagnostics na $4,676 nde, ebe akụkọ dị n'otu ntinye akwụkwọ na-enye $8.259 ijeri na $4.939 ijeri; okpokoro ahụ na-emekọrịta ọnụ na ngụkọta otu ugboro $(2,033) A na-etinye nde mkpochapụ, ya mere kwuo na tebụl.
Onye na-anya uto ekpughere bụ ikike mgbago na mgbada. Ahịrị bioproduction dị n'otu ntinye akwụkwọ ruru $3,200 nde in 2025, elu $548 nde, na bioproduction chụpụrụ Life Sciences Solutions uto organic; Mkparịta ụka nke akụkụ dị na 10-K na-etinye bioproduction n'etiti azụmaahịa atọ bụ isi na ngalaba ahụ wee detuo Septemba. 1, 2025 nnweta nke Solventum filtration na nkewa azụmahịa. Asụsụ njikọta bụ akụkụ ọrụ: Nkọwa nke akụkụ dị na ntinye akwụkwọ na-akọwa Laboratory Products na Biopharma Services ka ọ na-enye "ihe fọrọ nke nta ka ọ bụrụ ihe niile achọrọ maka ụlọ nyocha" na nyocha ụlọ ọgwụ dị ka "nke zuru oke., agbakwunyere mmepe ụlọ ọgwụ,” na njikwa kọwara onyinye Accelerator ya dị ka CDMO na CRO agbakwunyere na 2026-01-29 kpọọ. Ọ dịghị ihe ọ bụla dị n'ọgụgụ ederede zuru oke nke ntinye akwụkwọ na-akwado ịgụ nloghachi dị ka nkwado ọrụ peptide., nke bụ njedebe n'eziokwu nke mgbaàmà.
Kedu ihe bụ usoro nyocha peptide agbakwunyere, na ebee ka cross-ere handoffs na-eri oge na reproducibility?
Mgbama Pọtụfoliyo ahụ ekwughị ihe ọ bụla gbasara yinye nke nza peptide na-eme njem, ya mere malite na ihe yinye bụ. Usoro nyocha peptide agbakwunyere bụ usoro na-aga n'ihu, mbipute-achịkwa ndekọ si usoro imewe site njikọ, ime ka ọ dị ọcha, njirimara na mkpebi ntọhapụ, ka e wee nweta nza ọ bụla na usoro na usoro mepụtara ya. Ọnụ ego nke yinye gbajiri agbaji na-egosi na njikọ peptide na nchacha ọcha, ebe usoro ma ọ bụ usoro na-agafe ókèala ụlọ ọrụ. I Q2(R2) chọrọ ntugharị akụkụ ma ọ bụ zuru oke nke njirimara emetụtara yana / ma ọ bụ nyocha ntụle nke nlele ndị nnọchite anya n'etiti ịmalite na ịnata ụlọ nyocha mgbe usoro kwadoro., na oke ziri ezi site na usoro, mgbanwe na tupu ihe ọmụma. Matrix nkwado na ICH Q2(R2) na-eme ka ya pụta ihe: njirimara chọrọ nkọwapụta naanị, ebe ịdị ọcha na nyocha onye ọ bụla na-ebu njirimara nke ya, ya mere usoro ịdị ọcha HPLC bufee na-abịarute yana ọrụ agbakwunyere.
A na-akọwa ihe ọkwa nke ọ bụla ga-agafe na njedebe mmalite-ihe. Ntuziaka EMA na peptides sịntetik chọrọ ka akọwapụta usoro amino acid echedoro maka ọdịdị ya, njirimara, adịghị ọcha ndị metụtara ya (eantiomeric, diastereomeric, amino asịd na-enweghị nchebe, dipeptides, β-alanyl adịghị ọcha), ihe ndị ọzọ adịghị ọcha na nyocha, na ntule dị oke egwu nke mmalite ihe adịghị ọcha nwere ike imetụta profaịlụ adịghị ọcha nke peptide. Otu akaụntụ teknụzụ CDMO nke ihe kpatara na-enyefe aha mpụ na-efunahụ nghọta usoro, akụrụngwa iche iche na mbubreyo usoro mkpọchi, ma na-ekwu na usoro “nwere ike igbu oge na oge ụfọdụ, ghara ịmalite"; Ọ nweghị ebe dị na nhazi a na-akọwapụta ọnụọgụ ọrụ peptide kpọmkwem, ya mere were pasentị ọ bụla egosiri gị dị ka akwadobeghị.
Ntugharị igodo: Ndekọ ndekọ nke na-ejide ọdịda-nzọụkwụ nsụgharị bụ ọkwa-ọkwa: ụdị usoro, saịtị mgbanwe na kemistri, otutu, ID usoro, kọlụm, gradient, ogologo waveleng na ọkọlọtọ ntụaka, onye ọ bụla jikọtara na mkpebi ntọhapụ ọ kwadoro.
Kedu ihe ngwugwu data peptide ejikọrọ ga-ebu, na kedu ka ịdị ọcha si eme, njirimara, net peptide ọdịnaya, mgbochi na nkwụsi ike dị iche iche dị ka njirimara ntọhapụ?
Ogige ndị ahụ dị mkpa naanị ma ọ bụrụ na onye ọ bụla zara ajụjụ ntọhapụ dị iche, na ọ dịghị otu nọmba na-anọchi ọzọ. Ntuziaka EMA na peptides sịntetik na-esetịpụ ọnụ ụzọ adịghị ọcha metụtara peptide na 0.1% akuko, 0.5% mata na 1.0% tozuo, na-achọ ụzọ adịghị ọcha nwere ike izute 0.1% ngafe akuko, na-etinye aka na 1.0% oke iru eru na-ekpochapụ adịghị ọcha a na-ahụta dị ka otu ọnụ ọgụgụ kasị elu, ma na-atụ aro ma ọ dịkarịa ala ụzọ abụọ orthogonal maka njirimara na ntọhapụ. Ụbọchị dị irè otu ụkpụrụ ahụ bụ 1 June 2026, CHMP nakweere na 1 Disemba 2025 na CVMP na 4 Disemba 2025.
|
Hapụ àgwà |
Ajụjụ ọ zara |
Ịmepụta usoro |
Ụkpụrụ nchịkwa |
|---|---|---|---|
|
Ịdị ọcha |
Kedu ihe adịghị ọcha metụtara peptide Peptides na-abanye n'ime cell dị ugbu a, ma ọ dị n'elu 0.1%? |
HPLC nwere oke akuko nwere ike 0.1% |
Ọnụ ego EMA |
|
njirimara |
Ọ bụ usoro ihe a kapịrị ọnụ? |
Opekempe ụzọ abụọ orthogonal (MS, maapụ peptide, amino acid analysis, NMR) Ihe ngwọta Peptide |
EMA gu Peptides Supplier N'ogbe ideline |
|
Ọdịnaya peptide net |
Ego ole peptide base dị na vial? |
Nyocha site na LC, nyocha nke elemental, amino acid analysis, Kjeldahl nitrogen ma ọ bụ qNMR |
|
|
Mkpesa |
Kedu ụdị nnu, na ihe ziri ezi elu oke? |
Nnwale Counter-ion na ọdịnaya |
|
|
Nkwụsi ike |
Nza ahụ ka na-emezu nkọwapụta n'oge ekenyere ya? Polypeptide |
Ogologo oge, n'etiti na accelerated ọmụmụ |
Counterion bụ ebe nzaba-na-nza peptide na-agbaji nwayọọ nwayọọ. Nhọrọ nyocha dị na ntuziaka ahụ kwupụta nyocha na counter-ion-free, ndabere anhydrous ma kọwaa ike dị ka peptide base mass, na ngalaba counter-ion nke ntuziaka chọrọ njirimara counter-ion na ọdịnaya nwere oke elu ziri ezi, Ịrịba ama acetate na-emekarị ma trifluoroacetate ma ọ bụ chloride ga-ekwe omume. Echiche counter-ion nke ntuziaka ahụ pụtara nza abụọ n'otu ịdị ọcha HPLC nwere ike ịdị iche na peptide anapụta..
Chepụta ọmụmụ nkwụsi ike maka ihe, ojiji na mmepe ogbo. Ọmụmaatụ ndebanye aha Q1A anaghị ewebata otu gburugburu, n'etiti na ngwa ngwa imewe na nyocha ọ bụla peptide ma ọ bụ ọnọdụ nchekwa.
Jiri K/M naanị n'ụdị ngwaahịa na ọnọdụ ụzọ ya, na-agbanwe agbanwe dose nkeji. Nke nkịtị 5 Uru EU/kg maka iji nne na nna na-abụghị intrathecal abụghị akara zuru ụwa ọnụ maka ụzọ ọ bụla ma ọ bụ nyocha ụlọ nyocha.. Gosipụta usoro endotoxin dabara adaba ebe achọrọ nnwale.
⚠️ Ịdọ aka ná ntị: Ihe ezubere maka n'ime vivo ma ọ bụ iji ụlọ ọgwụ na-ebu ihe ndị ọzọ chọrọ ntozu karịrị njirimara dị n'elu. Jiri usoro nhazi na ịdịmma nke gị gosipụta oke tupu ị dabere na ngwungwu ndị na-ebubata ihe ọ bụla.
Otu anyị si etinye nke a na MOL Changes, onye bipụtara akwụkwọ ntuziaka a. Ọrụ nnwale peptide anyị na-ekpuchi ọtụtụ nkọwa maka njirimara, HPLC maka pasentị ịdị ọcha, pH, Mkpebi ọdịnaya peptide na nnwale endotoxin, na iwu gụnyere HPLC, MS na pH na-akọ, yabụ njirimara ntọhapụ ndị ahụ nwere ike ịbịarute dị ka ụkpụrụ atụpụtara kama ịbụ otu nọmba ịdị ọcha. Ihe anyị na-adịghị eme bụ ekwe nkwa nkwụsi ike: ọ dịghị akwụkwọ ahịa anyị jide na-ekwu a kwụsie ike omume, ya mere, nchekwa-ndụ na data nbibi ka bụ ọrụ nke onye na-agụ ya, gbakọtara na ọmụmụ nkwụsi ike nke onwe ha na onye ọ bụla na-ebubata ya, nke anyị gụnyere.
Kedu mkpebi mkpebi otu otu ga-etinye maka ikpebi ma usoro ọrụ peptide na ndị na-ebu ya nwere njikọ n'ezie?
N'iji njirimara ndị ahụ akọwapụtara, Nnwale bụ ma ngwugwu ndị na-ebubata ya na-eburu ha n'ezie, ya mere tinye ajụjụ ise na ezigbo ngwugwu ma kwụsị na nke mbụ na-ada. Mbụ, na-eme ngwugwu ahụ ụdị usoro usoro, saịtị mgbanwe na kemistri, na otutu na otu akwụkwọ dị ka nsonaazụ ya? Nke abụọ, njirimara na-adabere na opekata mpe ụzọ abụọ orthogonal, dị ka Ntuziaka EMA na peptides sịntetik na-atụ aro maka ntọhapụ? Nke atọ, usoro ịdị ọcha ọ nwere ezi akụkọ nwere ike gbadata ruo 0.1% n'okpuru I Q2(R2), karịa oke oke? Nke anọ, bụ counterion njirimara na ọdịnaya, mmiri na net net peptide kọrọ, kwa ngalaba counter-ion nke ntuziaka? Nke ise, bụ eletrọnịkị ndekọ ndekọ-njikere?
Ajụjụ ikpeazụ ahụ na-ebu usoro iwu. MHRA's GxP data iguzosi ike n'ezi ihe na-akọwa ALCOA dị ka Attributable, Enwere ike ịkọwa, Nke dịkọrọ ndụ, Mbụ na nke ziri ezi, ya na “+” na-agbakwunye Complete, Na-agbanwe agbanwe, Na-adịgide adịgide ma dị, ma kwuo na ọ dịghị ihe dị iche na atụmanya nke ọ bụla acronym eji. 21 CFR 11.10(e) chọrọ nchekwa, kọmputa emepụtara, Ụzọ nyocha nke stampụ oge nke na-adịghị ekpuchi data mbụ ma na-edobe ma ọ dịkarịa ala ma ọ bụrụhaala na isiokwu ahụ dekọtara., mgbe 11.10(a), (c) na (d) mkpuchi akwadoro usoro, iweghachite na njikwa ohere. 21 CFR 11.50 na 11.70 chọrọ ndekọ ọ bụla bịanyere aka n'akwụkwọ iji gosi aha ebibiri onye binyere aka, ụbọchị na oge, na ihe pụtara, na mbinye aka jikọtara ya mere enweghị ike iwepụ ya. Akụkụ FDA 11 Ntuzi aka zuru oke doro anya na mbipụta akwụkwọ anaghị ewepụ ọrụ ahụ mgbe ndekọ elektrọn bụ ihe ụlọ ọrụ ahụ dabere na ya..
Nnabata nke ndị na-ebubata ihe bụ ọnọdụ, ọ bụghị akpaka. 21 CFR 211.84 na-enye ohere ka onye na-eweta akụkọ nyocha nke nyocha n'ọnọdụ ịdị ọcha zuru oke, Nnwale ike na ịdị mma naanị ma ọ bụrụ na emere opekata mpe otu nnwale njirimara yana onye nrụpụta na-ewepụta ntụkwasị obi nke ndị na-ebubata ya site na nkwado na oge kwesịrị ekwesị.. I Q9(R1), dị irè 26 Julaị 2023, na-ejikọta ndị na-ebubata ihe nleba anya na nyocha ihe egwu ma kwuo na mmachi akụrụngwa ekwesịghị ịkwado usoro dị ala.. Ndị a bụ njirisi nyocha nke ndị na-ere peptide na-ekewa onye na-eweta ihe ejikọrọ na nke ngwa ngwa.
Maka ndụmọdụ: Gbaa ajụjụ ise ahụ megide otu ezigbo akwụkwọ nyocha nke izu a. "Ee e" na ajụjụ otu ma ọ bụ abụọ pụtara na enweghị ike ịdabere na ngwugwu ndị ọzọ maka mkpebi edoziziri.
Ajụjụ a na-ajụkarị
Ọrụ nke Thermo Fisher ọ pụtara na ọrụ peptide na-agbakọta?
Mba. Ọnụ ego nke Thermo Fisher 2025 akụkọ kwa afọ Enweghị aha maka "peptide" ma ọ bụ "peptides omenala,” yana onye ọkwọ ụgbọ ala ekpughere n'ime Life Sciences Solutions bụ bioproduction na $3,200 nde, elu $548 nde. Ọnụọgụ nloghachi bụ data ahịa ndị odee wetara nke dị iche site na isi mmalite na ụbọchị, ọ bụghị nkwupụta gbasara ikike peptide.
Nwere ike peptide abụọ n'otu ịdị ọcha HPLC na-ebuga peptide dị iche iche?
Ee. Ihe nyocha chọrọ na ntuziaka EMA kwupụta nyocha na counter-ion-free, ndabere anhydrous ma kọwaa ike dị ka peptide base mass, na ọdịnaya counter-ion ga-ejikwa oke elu ezighi ezi. Nza abụọ n'otu n'otu na-adị ọcha nwere ike ịdị iche na peptide a na-ebupụta mgbe agbachara mmiri na mmiri..
Bụ akwụkwọ nyocha nke ndị na-eweta ngwaahịa zuru oke iji wepụta nza peptide?
Naanị ọnọdụ. 21 CFR 211.84 na-enye ohere ịnakwere akụkọ nyocha nke ndị na-ebubata ngwaahịa n'ọnọdụ nyocha zuru oke ma ọ bụrụ na emere opekata mpe otu nnwale njirimara yana akwadoro ntụkwasị obi nke ndị na-ebubata ya n'oge kwesịrị ekwesị.. Nnwale njirimara na oge nkwado bụ isi ihe nchịkwa bara uru.
Mee ọnụ ụzọ adịghị ọcha peptide EMA dochie oke ICH Q3A?
Ee, maka peptides sịntetik. Ntuziaka EMA na peptides sịntetik na-ekwu na ewepụrụ peptides sịntetik na ICH Q3A/VICH GL10 yana Ph.. Euro. ụzọ peptide metụtara na-emetụta kama: akụkọ n'elu 0.1%, mata n'elu 0.5% ma tozuo oke 1.0%.
Mmechi
Ihe ewepụtara bụ na njikọ bụ ihe onwunwe nke ndekọ, ọ bụghị nke ndị na-eweta ngwaahịa. A na-ejikọta usoro ọrụ mgbe ụdị usoro, mgbanwe chemistry, otutu, ID usoro, kọlụm, gradient, ogologo waveleng na ụkpụrụ ntụaka njem ọnụ na ịdị ọcha, njirimara, net ọdịnaya, nsonaazụ na nkwụsi ike, na mgbe ndekọ ndị ahụ na-emezu ihe nyocha-nzọ ụkwụ na mbinye aka-njikọ chọrọ nke 21 CFR 11.10(e) na 21 CFR 11.50 na 11.70. Nzọụkwụ ọzọ bụ ịrịọ sample ngwungwu data ejikọrọ maka otu usoro nnọchite anya site n'aka onye na-ebubata gị ugbu a ma ọ bụ onye na-akwado ya wee gbaa ajụjụ ise ahụ megide ya.; ngwugwu nke na-adaghị ajụjụ otu ma ọ bụ abụọ abụghị oghere akwụkwọ mana ọ bụ ihe egwu mmụgharị nke ị tụlere ugbu a..
Nkpughe nke onye mbipụta: MOL Mgbanwe na-enye ọrụ peptide ma nwee mmasị azụmahịa na isiokwu a. Ogo ọrụ na nkwupụta ikike bụ nkwupụta ndị na-ebubata ya; nnweta na ịrụ ọrụ maka otu ihe owuwu chọrọ ihe akaebe akọwapụtara nke ọma.
